Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Vincent Rajkumar

Vincent Rajkumar


Academic history

Vincent Rajkumar is a Professor of Medicine at Mayo Clinic, Rochester, MN, the Editor-in-Chief of Blood Cancer Journal, and Associate Editor of the European Journal of Haematology. He is also currently a member of the National Institutes of Health Multiple Myeloma Steering Committee, Chair of the Myeloma Committee, Eastern Cooperative Oncology Group, and Co-Chair of the International Myeloma Working Group.

Prof. Rajkumar received his medical degree from the Christian Medical College, Vellore, India, and subsequently completed a residency in internal medicine at the University of North Dakota School of Medicine, Grand Forks, ND, as well as a fellowship in hematology/oncology at the Mayo Graduate School of Medicine, Mayo Clinic College of Medicine, Rochester, MN.

Speaking on myeloma and related disorders

Prof. Rajkumar’s main research interests are myeloma, amyloidosis and monoclonal gammopathy of undetermined significance (MGUS). He has previously undertaken research on novel therapies and biomarkers for multiple myeloma, the epidemiology and prognosis of myeloma and related monoclonal gammopathies, as well as racial disparities in myeloma.

Prof. Rajkumar has also recently been involved in several clinical trials relating to myeloma. Two such clinical trials include a Phase III clinical trial assessing the efficacy of ixazomib and/or lenalidomide in patients with newly diagnosed myeloma who are ineligible for stem cell transplant and a Phase II study assessing the efficacy and safety of elotuzumab in combination with lenalidomide, bortezomib, and dexamethasone in patients with myeloma.